11.06
Tyra Biosciences Inc Borsa (TYRA) Ultime notizie
Is Tyra Biosciences Inc. a good long term investmentAccelerated wealth expansion - Autocar Professional
What analysts say about Tyra Biosciences Inc. stockTremendous financial leverage - Autocar Professional
Tyra Biosciences Inc. Stock Analysis and ForecastHigh-return market picks - PrintWeekIndia
What drives Tyra Biosciences Inc. stock priceFree Capital Growth Strategies - PrintWeekIndia
Tyra Biosciences (NASDAQ:TYRA) Trading Down 3% – Here’s Why - Defense World
Why Tyra Biosciences Inc. stock attracts strong analyst attentionHigh Yield Opportunities - Newser
Achondroplasia Breakthrough? Tyra Biosciences CEO Reveals Latest Treatment Progress at UBS Fireside Chat - Stock Titan
June Brings on Some Huge Insider Buying - AOL.com
What analysts say about HOOK stockPhenomenal capital appreciation - jammulinksnews.com
Trading (TYRA) With Integrated Risk Controls - news.stocktradersdaily.com
What drives Diana Shipping Inc. stock priceSuperior profit margins - Jammu Links News
What drives Third Harmonic Bio Inc. stock priceOutstanding risk-reward balance - jammulinksnews.com
Tyra Biosciences Rises On Precision Medicine Hopes And Analyst Support - Finimize
What makes Tyra Biosciences Inc. stock price move sharplySmart Return Focused Trading - Newser
How Tyra Biosciences Inc. stock performs during market volatilityInsider Strategy Insight - Newser
Tyra Biosciences Insider Lowered Holding By 58% During Last Year - simplywall.st
Advanced Urothelial Carcinoma Clinical Trials 2025: EMA, PDMA, - openPR.com
Oppenheimer Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $30 - 富途牛牛
Tyra Biosciences Announces Late-Breaking Poster Presentation on TYRA-300 Preclinical Results at ENDO 2025 - Eastern Progress
Tyra Biosciences' TYRA-300 Emerges as Dual-Threat Therapy, Poised to Drive Clinical and Market Momentum - AInvest
New TYRA-300 Preclinical Data Reveals Promising Results for Rare Bone Growth Disorder Treatment - Stock Titan
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):